Article Text

PDF
AB0016 Interferon Regulatory Factor 5 (IRF5) Gene Variant Rs2004640 is Associated with Carotid Intimal Medial Thickness in Rheumatoid Arthritis Patients
  1. S. Vosslamber1,
  2. A.V. Sijl2,
  3. C. Bos1,
  4. A. Voskuyl2,
  5. M. Nirmohamed2,
  6. C. Verweij1
  1. 1Pathology
  2. 2Rheumatology, VU University Medical Center, Amsterdam, Netherlands

Abstract

Background Rheumatoid arthritis (RA) is a chronic inflammatory joint disease and is associated with increased cardiovascular (CV) risk. Interferons (IFNs), especially IFNβ, might play a role in atherosclerosis as they are known inhibitors of vascular smooth muscle cell proliferation and intimal hyperplasia.

Objectives We studied whether functional relevant SNPs in the interferon regulatory factor 5 (IRF5) gene are associated with carotic intima media thickness (cIMT), a surrogate maker for CV disease.

Methods In 353 RA patients of the CARRΈ study, IRF5 SNPs rs2004640 and rs4728142 were determined using Taqman Genotyping assay. cIMT was determined in 101 patients by B-mode ultrasonography. Linear regression analyses were used to investigate the association between cIMT and IRF5 genotypes, adjusted for demographic and cardiovascular risk factors.

Results Patients homozygous for rs2004640 G-allele had higher cIMT compared to those homozygote for the T-allele (p=0.019) and a trend towards higher cIMT was observed (p=0.103) for patients homozygous for the rs4728142 G-allele versus patients with the AA-genotype. Age was an effect-modifier for this association. Linear regression analysis in patients older than 60 years showed that the rs2004640 GG-genotype was associated with higher cIMT (regression coefficient 0.107 (C.I. 0.008; 0.205), p=0.035) compared to the TT-genotype. This remained significant after adjustment for traditional risk factors (regression coefficient 0.111 (C.I. 0. 02; 0.202), p=0.020).

Conclusions We demonstrate that IRF5 gene variant rs2004640 is associated with preclinical atherosclerosis in RA patients, independent of traditional cardiovascular risk factors. These results might implicate a role for type I IFN in modulating CV disease features in RA.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.4922

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.